152 related articles for article (PubMed ID: 3629708)
1. The antisickling role of uric acid in sickle cell disease.
Ekeke GI; Nduka N
Trop Geogr Med; 1987 Apr; 39(2):152-6. PubMed ID: 3629708
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricaemia in sickle cell disease.
Isichei UP
Trop Geogr Med; 1984 Dec; 36(4):351-4. PubMed ID: 6528354
[TBL] [Abstract][Full Text] [Related]
3. Antisickling effects of membrane-interacting compounds.
Ohnishi ST
Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
[TBL] [Abstract][Full Text] [Related]
4. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
5. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
Yu KH; Luo SF; Tsai WP; Huang YY
Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
[TBL] [Abstract][Full Text] [Related]
6. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid status of Nigerian children with sickle cell disease.
Adeyokunnu AA; Osanyintuyi VO
East Afr Med J; 1984 Feb; 61(2):145-9. PubMed ID: 6468321
[No Abstract] [Full Text] [Related]
8. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
[TBL] [Abstract][Full Text] [Related]
9. Serum urate concentrations in homozygous sickle cell disease.
De Ceulaer K; Morgan AG; Choo-Kang E; Wilson WA; Serjeant GR
J Clin Pathol; 1981 Sep; 34(9):965-9. PubMed ID: 7276221
[TBL] [Abstract][Full Text] [Related]
10. Liver function and the diagnostic significance of conjugated cholic acid and chenodeoxycholic acid in serum of African patients with sickle cell disease.
Bolarin DM
Acta Trop; 1983 Dec; 40(4):359-64. PubMed ID: 6142634
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
12. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
14. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
[TBL] [Abstract][Full Text] [Related]
15. Serum urate levels between ages 10 and 14: changes in sex trends.
Munan L; Kelly A; Petitclerc C
J Lab Clin Med; 1977 Dec; 90(6):990-6. PubMed ID: 925487
[TBL] [Abstract][Full Text] [Related]
16. Glomerular function and hyperuricaemia in sickle cell disease.
Morgan AG; De Ceulaer K; Serjeant GR
J Clin Pathol; 1984 Sep; 37(9):1046-9. PubMed ID: 6470183
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
Tavakkoli F; Nahavandi M; Wyche MQ; Castro O
Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of erythrocyte sickling by thiol reagents.
Garel MC; Domenget C; Galacteros F; Martin-Caburi J; Beuzard Y
Mol Pharmacol; 1984 Nov; 26(3):559-65. PubMed ID: 6493211
[TBL] [Abstract][Full Text] [Related]
19. Established and experimental treatments for sickle cell disease.
De Franceschi L; Corrocher R
Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia.
Athanassiou G; Moutzouri A; Kourakli A; Zoumbos N
Clin Hemorheol Microcirc; 2006; 35(1-2):291-5. PubMed ID: 16899945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
